State-of-the-art surgery for hepatocellular carcinoma

Background Hepatocellular carcinoma (HCC) is the most commonly diagnosed primary liver tumor with an increasing incidence worldwide. Management of patients with HCC is largely dictated by the presence of cirrhosis, disease stage, underlying liver function, and patient performance status. Purpose We provide an update on key aspects of surgical treatment options for patients with HCC. Results & Conclusions Liver resection and transplantation remain cornerstone treatment options for patients with early-stage disease and constitute the only potentially curative options for HCC. Selection of patients for surgical treatment should include a thorough evaluation of tumor characteristics and biology, as well as evidence-based use of various available treatment options to achieve optimal long-term outcomes for patients with HCC.

Automated summary

Liver resection and transplantation are the cornerstone treatment options for patients with early-stage disease, offering potentially curative options for HCC. Selection of patients for surgical treatment should involve thorough evaluation of tumor characteristics and biology, as well as evidence-based use of available treatment options to achieve optimal long-term outcomes.